Dr Alexander Strother reflects on his time designing and delivering a classroom-based programme to ensure that medical students know how to take comprehensive ophthalmic histories from patients. Working as a clinical teaching fellow, in 2021 I had the great privilege...
1 August 2018
| Gwyn Samuel Williams
|
EYE - General
I attended a morning seminar at the recent College Congress in Liverpool about how to properly and legally consent a patient for a procedure. There has been a lot of interest in this of late following the Montgomery ruling, in...
A 56-year-old type 2 diabetic with previously treated bilateral diabetic maculopathy develops a cataract requiring surgery in the right eye. He has had grid laser previously, followed intermittently by intravitreal triamcinalone, Avastin and more recently Lucentis in both eyes. His...
You’ve made into ophthalmic specialist training and before you know it, it’s your first on-call shift. You are expected to provide the specialist on-call service out of hours and there is a new wave of responsibility, with, let’s be honest,...
The authors summarise the main findings from a recent study which investigated the incidence rates of cataract in patients with or without diabetes mellitus (DM). Background to the study Worldwide, the World Health Organization (WHO) estimates that 253 million people...
Embarking on a taster week in ophthalmology at New Cross Hospital was a decision fuelled by the desire to delve into the intricacies of this unique specialty, which blends surgical and medical traits. For foundation doctors, a taster week is...
This study prospectively evaluated the use of ripasudil, a rho kinase inhibitor, in patients undergoing Descemet’s stripping only (DSO) without an endothelial graft for Fuch’s endothelial dystrophy (FED). Patients with dense central guttae limited to the central 5mm of the...
The aim was to investigate changes in ocular ductions in thyroid eye disease (TED) patients undergoing recession in comparison to recession / resection surgery. This was a retrospective study of 119 patients with inclusion of 102 eyes in final analysis....
Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...